SP-26-002: Strategic Prevention Framework - Partnerships for Success for Communities/Tribes
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2026.
Substance Abuse and Mental Health Services Adminis offered grants of up to $600,000 to the applicants described in the notice. It expected to make about 32 awards worth $8.0 million in total. Applications closed on July 10, 2026.
From the official notice on Grants.gov, last changed July 9, 2026. Checked November 7, 2026.
- Award ceiling$600,000
- Total funding$8.0 million
- Expected awards32
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 15, 2026 |
|---|---|
| Deadline | July 10, 2026 |
| Archived by Grants.gov | August 14, 2026 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is statutorily limited to political subdivisions of States; Indian tribes or tribal organizations (as such terms are defined in section 5304 of title 25); health facilities or programs operated by or in accordance with a contract or award with the Indian Health Service; or other public or private non-profit entities, including faith-based organizations.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to: help prevent and reduce the initiation and progression of substance use and its related problems by supporting the development and delivery of community-based substance use prevention services that strengthen protective factors, reduce risk factors, build resilience, and promote well-being and expand and strengthen the capacity of prevention providers serving communities and tribes to implement evidence-based and evidence-informed prevention strategies. IMPORTANT NOTE: SAMHSA will accept and review only the first 60 complete, successfully submitted, and high-quality applications received via eRA. Once this threshold is met, the submission portal will close, and no further applications will be considered.
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is SP-26-002 still open?
No. It closed on July 10, 2026.
Who can apply for Strategic Prevention Framework - Partnerships for Success for Communities/Tribes?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Strategic Prevention Framework - Partnerships for Success for Communities/Tribes?
Closed July 10, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $600,000 each. About $8.0 million in total across about 32 awards.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)